Different disease progression rate according to HIV-1 subtype

Future HIV Therapy

Volumn 2, Issue 4, 2008, Pages 319-322

  de Mendoza, Carmen ^a   Garrido, Carolina ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Coreceptor; Disease progression; Genetic diversity; HIV 1; Non B subtypes

Indexed keywords

ANTIRETROVIRUS AGENT; TENOFOVIR; TIPRANAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DISEASE CLASSIFICATION; DISEASE COURSE; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; MOLECULAR MECHANICS; NONHUMAN; UGANDA; VIREMIA; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 52349087317     PISSN: 17469600     EISSN: None     Source Type: Journal    
DOI: 10.2217/17469600.2.4.319     Document Type: Article

References (30)

1. Kiwanuka N, Laeyendecker O, Robb M et al.: Effect of human immumodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J. Infect. Dis. 197, 707-713 (2008).
2. McCutchan F: Global epidemiology of HIV. J. Med. Virol. 78, S7-S12 (2006).
3. Perrin L, Kaiser L, Yerly S: Travel and the spread of HIV-1 genetic variants. Lancet Infect. Dis. 3, 22-27 (2003).
4. Arien K, Abraha A, Quiñones-Mateu M et al.: The replicative fitness of primary HIV-1 group M, HIV-1 group O, and HIV-2 isolates. J. Virol. 79, 8979-8990 (2005).
5. Taylor B, Sobleszczyk M, McCutchan F, Hammer S: The challenge of HIV-1 subtype diversity. N. Engl. J. Med. 358, 1590-1602 (2008).
6. Kaleebu P, French N, Mahe C et al.: Effect, of HW type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1 positive persons in Uganda. J. Infect. Dis. 185, 1244-1250 (2002).
7. Baeten J, Chohan B, Lavreys L et al.: HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J. Infect. Dis. 195, 1177-1180 (2007).
8. Vasan A, Renjifo B, Hertzmark E et al.: Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin. Infect. Dis. 42, 843-852 (2006).
9. Lutalo T, Gray R, Wawer M et al.: Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda. AIDS 21, S15-S19 (2007).
10. Kanki P, Hamel D, Sankalé J et al.: Human immunodeficiency virus type 1 subtypes differ in disease progression. J. Infect. Dis. 179, 68-73 (1999).
11. Alaeus A, Lidman K, Bjorkman A et al.: Similar late of disease progression among individuals infected with HIV-1 genetic subtypes A-D. AIDS 13, 901-907 (1999).
12. Laurent C, Bourgeois A, Awa Faye M et al.: No difference in clinical progression between patients infected with predominant HIV-1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in western and west-central Africa: a four year prospective multicenter study. J. Infect. Dis. 186, 486-492 (2002).
13. Schuitemaker H, Koot M, Kootstra N et al.: Biological phenotype of HIV type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66, 1354-1360 (1992).
14. Kaleebu P, Nankya I, Yirrell D et al.: Relation between chemokine recaptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort. J. Acquir. Immune Defic. Syndr. 45, 28-33 (2007).
15. Huang W, Eshelman S, Toma J et al.: Coreceptor tropism in HIV-1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J. Virol. 81, 7885-7893 (2007).
16. Casper C, Clevestig P, Carlenor E et al.: Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child. J. Infect. Dis. 186, 914-921 (2002).
17. Nicastri E, Sarmati L, d'Etorre G et al.: Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy. J. Med. Virol. 69, 1-6 (2003).
18. Mellors J, Rinaldo C, Gupta P et al.: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167-1170 (1996).
19. Mellors J, Margolick J, Phair J et al.: Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA 297, 2349-2350 (2007).
20. Marlink R, Kanki P, Thior I et al.: Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265, 1587-1590 (1994).
21. Hu D, Vanichseni S, Mastro T et al.: Viral load differences in early infection with two HIV-1 subtypes. AIDS 15, 683-691 (2001).
22. Leroy V, Montcho C, Manigart O et al.: Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial. AIDS 15, 517-522 (2001).
23. Fawzi W, Msamanga G, Spiegelman D et al.: Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzanta. J. Acquir. Immune Defic. Syndr. 31, 331-338 (2002).
24. Renjifo B, Gilbert P, Chaplin B et al.: Preferential in utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. AIDS 18, 1629-1636 (2004).
25. Gao X, Nelson G, Karacki P et al.: Effect of a single amino acid change in MFC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344, 1668-1675 (2001).
26. Bannister W, Ruiz L, Loveday C et al.: HIV-1 subtypes and response to combination antiretroviral therapy in Eumpe. Antivir. Ther. 11, 707-715 (2006).
27. Geretti A, Harrison L, Green H, Dunn D: Exploring the effect of HIV-1 subtype on virological and immunological responses to first-line HAART. Presented at: 6th HIV European Drug Resistance Workshop. Budapest, Hungary, 26-28 March, 2008 (Abstract 30).
28. Garrido C, Zabonero N, Fernándes D et al.: Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola. J. Antimicrob. Chemother. 61, 694-698 (2008).
29. Brenner B, Oliveira M, Doualla-Bell F et al.: HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture. AIDS 20, F9-F13 (2006).
30. Poveda E, de Mendoza C, Parkin N et al.: Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes. AIDS 22, 611-616 (2008).